What is CENX's health score?

CENTURY ALUMINUM CO (CENX) has a TradeApes health score of 65 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is CENX's estimated fair value?

Based on our 5-year discounted cash flow model, CENTURY ALUMINUM CO's estimated fair value is $9.58 per share, representing a -76.9% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is CENX undervalued or overvalued?

Our model currently rates CENX as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

4 free score cards remaining

CENTURY ALUMINUM CO (CENX)

Materials Overvalued low healthy

$41.5

Updated: 2026-07-18

TradeApes Score

Financial Strength

80 Strong

Operating Trend

60 Healthy

Relative Value

60 Healthy

Capital Allocation

45 Mixed

Risk Management

80 Strong

Est. Fair Value $9.58

DCF Upside -76.9%

Sector Rank #777 of 2664

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Low FCF yield — below 1%, price implies exceptional future growth

Unlock Full Report →

Industry Related Stocks

Alcoa Corp (AA) AMERICAN BATTERY TECHNOLOGY Co (ABAT) ASCENT INDUSTRIES CO. (ACNT) American Clean Resources Group, Inc. (ACRG) ADURO CLEAN TECHNOLOGIES INC. (ADUR) ALBEMARLE CORP (ALB)

See all Materials stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.